In humans, mutations in complement protein and complement regulatory protein genes lead to increased susceptibility to preeclampsia (133, 134) and others suggest that complement cleavage products C3a and Bb can serve as predictors of preeclampsia (94, 135). This evidence concerns the gene VTN and preeclampsia.